Agenus | AGEN - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
AbbVie USD -5.94B 721M 2026-06
Agenus USD -199.08M 22.15M 2026-06
Amgen USD 11.69B 2.5B 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Celldex Therapeutics USD 714.56M 258.34M 2026-06
CSL USD 18.66B 2.75B 2025-12
Eli Lilly USD 33.88B 2.68B 2026-06
Gilead Sciences USD 11.74B 11.77B 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
Glaxosmithkline GBP 17.42B 4.64B 2026-03
Incyte USD 6.34B 721.58M 2026-06
Intrexon USD 43.17M 75.33M 2024-06
J&J USD 84.97B 3.78B 2026-06
Jiangsu Hengrui CNY 64.47B 840.17M 2026-06
Karyopharm Therapeutics USD -265.65M 27.28M 2026-03
MacroGenics USD 42.87M 21.68M 2026-06
Merck EUR 30.17B 430M 2026-06
Merck USD 41.93B 3.94B 2026-06
Northwest Biotherapeutics USD -50.54M 58.1M 2026-03
Novartis USD 41.95B 3.02B 2026-06
Novavax USD -190.71M 45.94M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Veracyte USD 1.39B 44M 2026-06